Advertisement

Topics

Nascent Pharmaceuticals, Inc. Company Profile

13:59 EDT 25th June 2018 | BioPortfolio

Nascent Pharmaceuticals, Inc. is a privately held company funded by individual and institutional investors.Nascent’s lead institutional investor is Advantage Capital Partners, a private equity firm. Since 1992 Advantage has raised more than $700 million in institutional capital and has invested in a wide variety of companies and real estate projects. The firm targets its investment activities in geographic areas that are underserved by venture capital.

Location

533 Airport Boulevard, Suite 400
Burlingame
California
94010
United States of America

Contact

Phone: 919-806-4569
Email: readingc@nascentpharma.com


News Articles [494 Associated News Articles listed on BioPortfolio]

Global delay in nascent strand DNA methylation

Proteomics: Nascent proteome labeling in vivo

Author Correction: Global delay in nascent strand DNA methylation

Vms1 and ANKZF1 peptidyl-tRNA hydrolases release nascent chains from stalled ribosomes

The (still somewhat mysterious) science behind the microbiome

Though nascent, microbiome research is offering valuable insights about how tiny organisms improve — and threaten — human health.

Generics likely to suffer most from Trump's trade war with China

The global pharmaceutical industry will be one casualty of US President Trump’s nascent trade war with…

Building A Biosimilars Market: Lessons From The US Launches

Provider trust in the biosimilar is as important as price in the nascent market and biosimilars need more commercialization support...   

Biosimilar sales remain small in 'largely untapped' market

Many unanswered questions surrounding the nascent biosimilar market are creating challenges â though less regulated markets may benefit from 'less well defined' definitions, says analyst.

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]

EYEWASH STATION ADDITIVE CONCENTRATE

PubMed Articles [200 Associated PubMed Articles listed on BioPortfolio]

Measuring Nascent Transcripts by Nascent-seq.

A complete understanding of transcription and co-transcriptional RNA processing events by polymerase requires precise and robust approaches to visualize polymerase progress and quantify nascent transc...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Pervasive Targeting of Nascent Transcripts by Hfq.

Hfq is an RNA chaperone and an important post-transcriptional regulator in bacteria. Using chromatin immunoprecipitation coupled with high-throughput DNA sequencing (ChIP-seq), we show that Hfq associ...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

Clinical Trials [218 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1329 Associated Companies listed on BioPortfolio]

Nascent Pharmaceuticals, Inc.

Nascent Pharmaceuticals, Inc. is a privately held company funded by individual and institutional investors.Nascent’s lead institutional investor is Advantage Capital Partners, a private equity firm....

Nascent Biotech, Inc.

Nascent Biotech, Inc is a clinical-stage biotech company engaged in the development of monoclonal antibodies to be used in the treatment of various cancers. Its products are not c...

Atlantic Technology Ventures Incorproated

Atlantic Technology Ventures, Inc. (OTC: ATLC.OB), formerly known as Atlantic Pharmaceuticals, Inc., is a technology incubator engaged in developing and commercializing a diverse portfolio of patented...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Nascent Biotech Inc.

NBI is a biotechnology company developing human Monoclonal Antibodies (mAb’s) for immunotherapy of cancer. Its lead therapeutic candidate, Pritumumab, was the first human ant...

More Information about "Nascent Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Nascent Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Nascent Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Nascent Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Nascent Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Nascent Pharmaceuticals, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record